Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesRSNA 2025GLP-1 drugs reduce heart plaque progression in diabetes patientsStudy findings could be good news for people with diabetes, as they tend to be at higher risk of cardiovascular disease.RSNA 2025Imaging can help 'All of Us'RSNA 2025GE HealthCare features new MRI scanners, PCCT systemRSNA 2025Abdominal obesity linked to heart damageRSNA 2025Breast cancer incidence rising in younger women